07.24.23 -- mAbs On The Express Lane

In the biotech industry, being able to quickly produce a batch at the right time and at the right size is essential to support development and get to the finish line faster. Learn how a CTDMO accelerates paths to compress processes while minimizing risk and ensuring product quality.

Getting your antibody to clinical trials faster while building a robust, scalable, and high-yielding process is a challenge many biotech companies face. Here, we showcase our purification development platform and how it enabled Igyxos Biotherapeutics to simplify and accelerate their clinical trial supply while achieving high-quality material.

Making the right decisions at the right time is crucial to the success of a biopharma executive. In this guidebook, experts share key considerations to help biopharmaceutical companies successfully advance a molecule from laboratory to clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety.